
Minimal impact from Trump’s drug pricing order
KUALA LUMPUR: An executive order signed by US President Donald Trump is not seen to have much impact on the Malaysian pharmaceutical sector, though there could be increased scrutiny on drug costs and the local supply chain. In his signed order, Trump had …